Growth at Reasonable Price
Results
4
1 new
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
PHM | €68.75 | 0.7% | -13.1% | €1.2b | €106.11 | 14.8 | 31.7% | 1.2% | Pharmaceuticals & Biotech | ||
TUB | €3.29 | -0.5% | -18.2% | €406.2m | €4.17 | 0.6 | 75.5% | 6.2% | Materials | ||
ROVI | €58.70 | 0.4% | 8.7% | €3.0b | €75.38 | 22.8 | 16.6% | 1.6% | Pharmaceuticals & Biotech | ||
IDR New | €53.60 | -2.4% | 61.5% | €9.7b | €66.16 | 20.8 | 14.3% | 0.6% | Software |
Page 1 of 1
